The importance of the erk pathway in the development of linker for activation of T cells-mediated autoimmunity

Journal of Immunology

Volumn 189, Issue 8, 2012, Pages 4005-4013

  Fuller, Deirdre M ^a   Zhu, Minghua ^a   Koonpaew, Surapong ^a   Nelson, Mariana I ^a   Zhang, Weiguo ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CARRIER PROTEIN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN G1; LAT PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHOLIPASE C GAMMA1; PROTEIN GADS; RAS GUANYL RELEASING PROTEIN 1; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR NFAT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ARTICLE; AUTOIMMUNITY; CD4+ T LYMPHOCYTE; CELL MATURATION; CELL SURVIVAL; CONTROLLED STUDY; HOMEOSTASIS; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; MOUSE; MUTATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; AUTOIMMUNE DISEASES; GUANINE NUCLEOTIDE EXCHANGE FACTORS; LYMPHOPROLIFERATIVE DISORDERS; MAP KINASE SIGNALING SYSTEM; MEMBRANE PROTEINS; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; PHOSPHOPROTEINS; RAF KINASES; RECEPTORS, ANTIGEN, T-CELL;

EID: 84867316974     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1201380     Document Type: Article

References (33)

1. Finco, T. S., T. Kadlecek, W. Zhang, L. E. Samelson, and A. Weiss. 1998. LAT is required for TCR-mediated activation of PLCgamma1 and the Ras pathway. Immunity 9: 617-626. (Pubitemid 28557590)
2. Zhang, W., C. L. Sommers, D. N. Burshtyn, C. C. Stebbins, J. B. DeJarnette, R. P. Trible, A. Grinberg, H. C. Tsay, H. M. Jacobs, C. M. Kessler, et al. 1999. Essential role of LAT in T cell development. Immunity 10: 323-332. (Pubitemid 29165287)
3. Zhang, W., J. Sloan-Lancaster, J. Kitchen, R. P. Trible, and L. E. Samelson. 1998. LAT: the ZAP-70 tyrosine kinase substrate that links T cell receptor to cellular activation. Cell 92: 83-92. (Pubitemid 28053300)
4. Zhang, W., R. P. Trible, M. Zhu, S. K. Liu, C. J. McGlade, and L. E. Samelson. 2000. Association of Grb2, Gads, and phospholipase C-gamma 1 with phosphorylated LAT tyrosine residues: effect of LAT tyrosine mutations on T cell antigen receptor-mediated signaling. J. Biol. Chem. 275: 23355-23361. (Pubitemid 30646238)
5. Liu, S. K., N. Fang, G. A. Koretzky, and C. J. McGlade. 1999. The hematopoietic-specific adaptor protein gads functions in T-cell signaling via interactions with the SLP-76 and LAT adaptors. Curr. Biol. 9: 67-75. (Pubitemid 29083530)
6. Yoder, J., C. Pham, Y. M. Iizuka, O. Kanagawa, S. K. Liu, J. McGlade, and A. M. Cheng. 2001. Requirement for the SLP-76 adaptor GADS in T cell development. Science 291: 1987-1991. (Pubitemid 32217002)
7. Ebinu, J. O., D. A. Bottorff, E. Y. Chan, S. L. Stang, R. J. Dunn, and J. C. Stone. 1998. RasGRP, a Ras guanyl nucleotide-releasing protein with calcium- and diacylglycerol-binding motifs. Science 280: 1082-1086. (Pubitemid 28234950)
8. Ebinu, J. O., S. L. Stang, C. Teixeira, D. A. Bottorff, J. Hooton, P. M. Blumberg, M. Barry, R. C. Bleakley, H. L. Ostergaard, and J. C. Stone. 2000. RasGRP links T-cell receptor signaling to Ras. Blood 95: 3199-3203. (Pubitemid 30321173)
9. Dower, N. A., S. L. Stang, D. A. Bottorff, J. O. Ebinu, P. Dickie, H. L. Ostergaard, and J. C. Stone. 2000. RasGRP is essential for mouse thymocyte differentiation and TCR signaling. Nat. Immunol. 1: 317-321.
10. Sommers, C. L., C. S. Park, J. Lee, C. Feng, C. L. Fuller, A. Grinberg, J. A. Hildebrand, E. Lacaná, R. K. Menon, E. W. Shores, et al. 2002. A LAT mutation that inhibits T cell development yet induces lymphoproliferation. Science 296: 2040-2043. (Pubitemid 34627529)
11. Aguado, E., S. Richelme, S. Nuñez-Cruz, A. Miazek, A. M. Mura, M. Richelme, X. J. Guo, D. Sainty, H. T. He, B. Malissen, and M. Malissen. 2002. Induction of T helper type 2 immunity by a point mutation in the LAT adaptor. Science 296: 2036-2040. (Pubitemid 34627528)
12. Archambaud, C., A. Sansoni, M. Mingueneau, E. Devilard, G. Delsol, B. Malissen, and M. Malissen. 2009. STAT6 deletion converts the Th2 inflammatory pathology afflicting Lat(Y136F) mice into a lymphoproliferative disorder involving Th1 and CD8 effector T cells. J. Immunol. 182: 2680-2689.
13. Chuck, M. I., M. Zhu, S. Shen, and W. Zhang. 2010. The role of the LAT-PLC-gamma1 interaction in T regulatory cell function. J. Immunol. 184: 2476-2486.
14. Shen, S., M. I. Chuck, M. Zhu, D. M. Fuller, C. W. Yang, and W. Zhang. 2010. The importance of LAT in the activation, homeostasis, and regulatory function of T cells. J. Biol. Chem. 285: 35393-35405.
15. Shen, S., M. Zhu, J. Lau, M. Chuck, and W. Zhang. 2009. The essential role of LAT in thymocyte development during transition from the double-positive to single-positive stage. J. Immunol. 182: 5596-5604.
16. Hayden-Martinez, K., L. P. Kane, and S. M. Hedrick. 2000. Effects of a constitutively active form of calcineurin on T cell activation and thymic selection. J. Immunol. 165: 3713-3721. (Pubitemid 32057277)
17. Yablonski, D., T. Kadlecek, and A. Weiss. 2001. Identification of a phospholipase C-gamma1 (PLC-gamma1) SH3 domain-binding site in SLP-76 required for T-cell receptor-mediated activation of PLC-gamma1 and NFAT. Mol. Cell. Biol. 21: 4208-4218. (Pubitemid 32565303)
18. Singer, A. L., S. C. Bunnell, A. E. Obstfeld, M. S. Jordan, J. N. Wu, P. S. Myung, L. E. Samelson, and G. A. Koretzky. 2004. Roles of the proline-rich domain in SLP-76 subcellular localization and T cell function. J. Biol. Chem. 279: 15481-15490. (Pubitemid 38618948)
19. Koonpaew, S., S. Shen, L. Flowers, and W. Zhang. 2006. LAT-mediated signaling in CD4+CD25+ regulatory T cell development. J. Exp. Med. 203: 119-129. (Pubitemid 43139651)
20. Clipstone, N. A., and G. R. Crabtree. 1992. Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation. Nature 357: 695-697.
21. Karin, M., and Y. Ben-Neriah. 2000. Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu. Rev. Immunol. 18: 621-663. (Pubitemid 30365393)
22. Sasaki, Y., E. Derudder, E. Hobeika, R. Pelanda, M. Reth, K. Rajewsky, and M. Schmidt-Supprian. 2006. Canonical NF-kappaB activity, dispensable for B cell development, replaces BAFF-receptor signals and promotes B cell proliferation upon activation. Immunity 24: 729-739. (Pubitemid 43867365)
23. Iritani, B. M., K. A. Forbush, M. A. Farrar, and R. M. Perlmutter. 1997. Control of B cell development by Ras-mediated activation of Raf. EMBO J. 16: 7019-7031. (Pubitemid 27520802)
24. Iritani, B. M., J. Alberola-Ila, K. A. Forbush, and R. M. Perimutter. 1999. Distinct signals mediate maturation and allelic exclusion in lymphocyte progenitors. Immunity 10: 713-722. (Pubitemid 29302924)
25. Wang, Y., A. Kissenpfennig, M. Mingueneau, S. Richelme, P. Perrin, S. Chevrier, C. Genton, B. Lucas, J. P. DiSanto, H. Acha-Orbea, et al. 2008. Th2 lymphoproliferative disorder of LatY136F mutant mice unfolds independently of TCR-MHC engagement and is insensitive to the action of Foxp3+ regulatory T cells. J. Immunol. 180: 1565-1575.
26. Mingueneau, M., R. Roncagalli, C. Grégoire, A. Kissenpfennig, A. Miazek, C. Archambaud, Y. Wang, P. Perrin, E. Bertosio, A. Sansoni, et al. 2009. Loss of the LAT adaptor converts antigen-responsive T cells into pathogenic effectors that function independently of the T cell receptor. Immunity 31: 197-208.
27. Ruan, Q., V. Kameswaran, Y. Tone, L. Li, H. C. Liou, M. I. Greene, M. Tone, and Y. H. Chen. 2009. Development of Foxp3(+) regulatory T cells is driven by the c-Rel enhanceosome. Immunity 31: 932-940.
28. Long, M., S. G. Park, I. Strickland, M. S. Hayden, and S. Ghosh. 2009. Nuclear factor-kappaB modulates regulatory T cell development by directly regulating expression of Foxp3 transcription factor. Immunity 31: 921-931.
29. Mantel, P. Y., N. Ouaked, B. Rückert, C. Karagiannidis, R. Welz, K. Blaser, and C. B. Schmidt-Weber. 2006. Molecular mechanisms underlying FOXP3 induction in human T cells. J. Immunol. 176: 3593-3602.
30. Miyaji, M., R. L. Kortum, R. Surana, W. Li, K. D. Woolard, R. M. Simpson, L. E. Samelson, and C. L. Sommers. 2009. Genetic evidence for the role of Erk activation in a lymphoproliferative disease of mice. Proc. Natl. Acad. Sci. USA 106: 14502-14507.
31. Chau, L. A., and J. Madrenas. 1999. Phospho-LAT-independent activation of the ras-mitogen-activated protein kinase pathway: a differential recruitment model of TCR partial agonist signaling. J. Immunol. 163: 1853-1858. (Pubitemid 29382185)
32. Fischer, A. M., C. D. Katayama, G. Pagès, J. Pouysségur, and S. M. Hedrick. 2005. The role of erk1 and erk2 in multiple stages of T cell development. Immunity 23: 431-443. (Pubitemid 41443444)
33. Alberola-Ila, J., K. A. Hogquist, K. A. Swan, M. J. Bevan, and R. M. Perlmutter. 1996. Positive and negative selection invoke distinct signaling pathways. J. Exp. Med. 184: 9-18. (Pubitemid 26247210)